ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IMNM vs XNCR // RETURN ON INVESTED CAPITAL (ROIC)

Immunome Inc. (NASDAQ) VS. Xencor Inc. (NASDAQ) • 15-METRIC TALLY: IMNM 1 — XNCR 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: XNCR
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMNM VS. XNCR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IMNM XNCR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -21.30% -13.70 XNCR /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.29% -6.37% -2.92 XNCR /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -23.20% 13.70% -36.90 XNCR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 25.03 4.32 +20.71 IMNM /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 XNCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.0 68.0 -21.97 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.16B $2.17B -$13.6M XNCR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IMNM REV XNCR REV IMNM GROSS % XNCR GROSS % IMNM FCF XNCR FCF
FY 2025 $6.9M $125.6M — — -$200.6M -$138.3M
FY 2024 $9.0M $110.5M — — -$118.0M -$208.3M
FY 2023 $14.0M $174.6M — — -$7.6M -$77.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMNM // BETA —
XNCR // BETA —